Clinical Trials
6
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
- Conditions
- Surgical Site InfectionsInfectionsSurgical Wound InfectionsAnti-Infective Agents
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- Ondine Biomedical Inc.
- Target Recruit Count
- 4740
- Registration Number
- NCT07189858
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
- Conditions
- Surgical Site InfectionsSurgical Wound InfectionInfectionsAnti-Infective Agents
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Ondine Biomedical Inc.
- Target Recruit Count
- 4514
- Registration Number
- NCT06702878
- Locations
- 🇺🇸
Swedish Medical Center, Englewood, Colorado, United States
🇺🇸HCA Brandon Florida, Brandon, Florida, United States
🇺🇸HCA Florida Largo Hospital, Largo, Florida, United States
Red Light Photobiomodulation and Topical Disinfectants
- Conditions
- Surgical Site InfectionHealthcare Associated InfectionNosocomial Infection
- First Posted Date
- 2023-04-04
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Ondine Biomedical Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT05797818
- Locations
- 🇺🇸
Ondine Research Laboratories, Bothell, Washington, United States
Photodynamic Therapy for COVID-19 Prevention
- Conditions
- SARS-CoV-2 Acute Respiratory DiseaseCOVID-19 Respiratory Infection
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-08-12
- Lead Sponsor
- Ondine Biomedical Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05184205
- Locations
- 🇪🇸
Clinica Universidad de Navarra, Pamplona, Spain
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
- Conditions
- Surgical Site InfectionsHealthcare Associated InfectionsNosocomial Infection
- First Posted Date
- 2021-10-25
- Last Posted Date
- 2022-08-22
- Lead Sponsor
- Ondine Biomedical Inc.
- Target Recruit Count
- 322
- Registration Number
- NCT05090657
- Locations
- 🇺🇸
Memorial University Medical Center, Savannah, Georgia, United States
- Prev
- 1
- 2
- Next
News
Ondine Biomedical's Steriwave Technology Shows 99.9% Efficacy Against Drug-Resistant C. auris as European Cases Surge 67%
Ondine Biomedical's Steriwave photodisinfection technology demonstrated 99.9% eradication of Candidozyma auris, a deadly drug-resistant fungus that has increased by 67% in European hospitals year-over-year.
King's College Hospital to Pilot Ondine Biomedical's Steriwave for HAI Prevention
King's College Hospital will pilot Ondine Biomedical's Steriwave technology as part of a quality improvement initiative to prevent hospital-acquired infections (HAIs).